Sunday, March 26, 2023
Home Breaking News Cory Booker Sends MindMed (MNMD) Stock Up 10%

Cory Booker Sends MindMed (MNMD) Stock Up 10%

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

Source: Daniel Patrick Martin /

Mind Medicine (NASDAQ:MNMD) stock is heating up on Tuesday thanks to Tweets from Sen. Cory Booker (D-NJ).

In a video Tweet, the Senator discussed the regulations surrounding psychedelics. He notes that this keeps them from seeing therapeutic use, despite recent research that suggests there’s such a case for them.

During his Tweets, Booker references his and Sen. Rand Paul’s (R-KY)”Right to Try” bill. This is legislation that would allow incredibly ill patients to try certain restricted drugs, such as psilocybin and marijuana.

Here’s a portion of what Booker says in the video, as transcribed by Marijuana Moment.

“We see that some drugs, like certain psychedelics, can help vulnerable people deal with their addiction, their trauma, their anxiety, their depression and more. Let’s make these drugs available for research, study and—ultimately, hopefully—for constructive application.”

Why MNMD Stock is Rising

All of those discussions are incredibly important to MindMed. The company’s main focus is on using psychedelics as a form of treatment for certain patients. The idea of a bill easing access to these types of drugs has investors excited today.

With that excitement comes heavy trading of MNMD stock. As of this writing, more than 2.6 million shares of the stock have been traded. To put that in perspective, the company’s daily average trading volume is closer to 1.3 million shares.

MNMD stock is up 9.9% as of Tuesday morning.

There’s more of the latest stock market news worth diving into below!

Most Popular

CPMD Receives Cultivation License from Heath Canada | All Finance Times

$30 Million in Revenues Projected over 12 Months CannaPharmaRx ( OTCMKTS: CPMD ) announced on December 22nd, 2022, that Health Canada has...

Canadian Cannabis; Down but Far from Out – Growth for 2023 and Beyond

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) -, a leading investor news resource covering cannabis and wellness...

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million

CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging...

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million

CALGARY, AB / ACCESSWIRE / December 21, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD) (the "Company"), an emerging leader in development and operation...


Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts